J W Kolaczynski Selected Research

Metformin (Glucophage)

1/2019

Mealtime fast-acting insulin aspart versus insulin aspart for controlling postprandial hyperglycaemia in people with insulin-resistant Type 2 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J W Kolaczynski Research Topics

Disease

1	Type 2 Diabetes Mellitus (MODY) 01/2019

Drug/Important Bio-Agent (IBA)

1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Insulin (Novolin)FDA Link 01/2019
1	Metformin (Glucophage)FDA LinkGeneric 01/2019
1	Insulin Aspart (NovoLog)FDA Link 01/2019

Therapy/Procedure

1	Therapeutics 01/2019